high - Office demand is highly correlated with white-collar employment growth, corporate profit margins, and business formation rates. Technology sector health is particularly critical given KRC's West Coast concentration and tenant mix skewed toward tech, media, and life science companies. Economic slowdowns trigger reduced space requirements, increased sublease availability, and downward pressure on asking rents. Life science segment provides partial insulation due to less cyclical biotech funding and pharmaceutical R&D spending, though venture capital availability affects emerging biotech tenant demand.

Rising interest rates negatively impact KRC through multiple channels: (1) higher cap rates compress property valuations and NAV, (2) increased borrowing costs on floating-rate debt and refinancings reduce FFO, (3) REIT dividend yields become less attractive relative to risk-free Treasury yields, causing multiple compression, and (4) higher discount rates reduce NPV of development projects. The company's 0.89x debt-to-equity ratio and estimated $2.5-3.0 billion debt balance create meaningful refinancing risk. Each 100bps increase in rates reduces development returns by approximately 150-200bps, potentially shelving marginal projects.

value - The 0.7x price-to-book ratio and 15% FCF yield attract deep value investors betting on office market stabilization and NAV realization through asset sales or portfolio repositioning. Contrarian investors see opportunity in West Coast office recovery as hybrid work policies stabilize and companies prioritize quality space. Dividend-focused investors are drawn to the estimated 5-6% dividend yield, though distribution sustainability depends on maintaining occupancy and refinancing debt at manageable rates. Growth-oriented investors focus on life science portfolio expansion potential.